Back to Search
Start Over
Ouabain inhibits p38 activation in mice neutrophils.
- Source :
-
Inflammopharmacology [Inflammopharmacology] 2021 Dec; Vol. 29 (6), pp. 1829-1833. Date of Electronic Publication: 2021 Nov 18. - Publication Year :
- 2021
-
Abstract
- Ouabain is a cardiac steroid hormone with immunomodulatory effects. It inhibits neutrophils migration induced by different stimuli, but little is known about the mechanisms involved in this effect. Thus, the aim of this study was to evaluate the ouabain effect on chemotactic signaling pathways in neutrophils. For that, mice neutrophils were isolated from bone marrow, treated with ouabain (1, 10, and 100 nM) for 2 h, submitted to transwell chemotaxis assay and flow cytometry analysis of Akt, ERK, JNK, and p38 phosphorylation induced by zymosan. Ouabain treatment (1, 10 and, 100 nM) reduces neutrophil chemotaxis induced by chemotactic peptide fMLP, but this substance did not inhibit Akt, ERK, and JNK activation induced by zymosan. However, ouabain (1 and 10 nM) reduced p38 phosphorylation in zymosan-stimulated neutrophils. These results suggest that ouabain may interfere in neutrophil migration through p38 MAPK inhibition.<br /> (© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Subjects :
- Animals
Cell Movement drug effects
Chemotaxis, Leukocyte drug effects
Dose-Response Relationship, Drug
Female
Flow Cytometry
Mice
Neutrophils metabolism
Ouabain administration & dosage
Phosphorylation drug effects
Signal Transduction drug effects
p38 Mitogen-Activated Protein Kinases metabolism
Neutrophils drug effects
Ouabain pharmacology
p38 Mitogen-Activated Protein Kinases antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1568-5608
- Volume :
- 29
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Inflammopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 34792671
- Full Text :
- https://doi.org/10.1007/s10787-021-00882-z